NCT02224768
- Conditions
- Advanced Melanoma
- Locations
-
- Bristol-Myers Squibb Princeton, New Jersey, United States
- Local Institution St Ives, Cambridgeshire, United Kingdom
Clinical trial condition
Advanced Melanoma
Explore clinical trials studying Advanced Melanoma. Study availability and eligibility vary by location and protocol.
67 public trials
22 recruiting studies
Advanced Melanoma trial results
NCT00920907
- Conditions
- Advanced Melanoma
- Locations
-
- The Angeles Clinic & Research Inst. Los Angeles, California, United States
- California Pacific Medical Center San Francisco, California, United States
- H Lee Moffitt Cancer Center Tampa, Florida, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00796991
- Conditions
- Advanced Melanoma
- Locations
-
- The Angeles Clinic & Research Inst. Los Angeles, California, United States
- H Lee Moffit Cancer Cnt And Res Inst Tampa, Florida, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Blumenthal Cancer Center, Carolinas Medical Center Charlotte, North Carolina, United States
NCT00542893
- Conditions
- Advanced Melanoma
- Locations
-
Not specified
NCT00688090
- Conditions
- Advanced Melanoma, Melanoma, Neoplasms, +11 more
- Locations
-
- UCLA Medical Center Los Angeles, California, United States
- H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States
NCT00197912
- Conditions
- Advanced Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark
Active, Not Recruiting
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
NCT04462406
- Conditions
- Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, +8 more
- Locations
-
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
Active, Not Recruiting
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
NCT02650986
- Conditions
- Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm, +78 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, Not Recruiting
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
NCT01134614
- Conditions
- Advanced Melanoma, Melanoma, Metastatic Melanoma, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- VA Palo Alto Health Care System Palo Alto, California, United States
- Eisenhower Medical Center Rancho Mirage, California, United States
Active, Not Recruiting
A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
NCT03311308
- Conditions
- Advanced Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Univ of Pittsburgh Medical Center Hillman Cancer Center Pittsburgh, Pennsylvania, United States